-
Data backs Boston Scientific drug-eluting stent
23 Apr 2025 18:29 GMT
… the use of its Eluvia drug-eluting stent for treating PAD.
The company … evidence supporting the Eluvia stent for treating peripheral artery disease (PAD) — … particularly in the superficial femoral artery (SFA) and femoropopliteal segments.
Boston …
-
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDE® Drug Eluting Bioresorbable Scaffold
22 Apr 2025 10:00 GMT
… for treating peripheral arterial disease (PAD), … ’s next generation drug eluting bioresorbable scaffold, MAGNITUDE … to the American Heart Association affects more … drug eluting sirolimus coated vascular scaffolds. These are designed to deliver the ‘stent …
-
R3 Vascular reports first patient treated in next-gen drug-eluting scaffold study
22 Apr 2025 20:59 GMT
… -BTK pivotal trial of its drug-eluting bioresorbable scaffold.
Dr. Brian DeRubertis … -generation Magnitude drug-eluting bioresorbable scaffold for below-the-knee peripheral arterial disease … designed Magnitude to deliver the “stent-like” support of a scaffold …
-
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
22 Apr 2025 11:17 GMT
… study demonstrating the SurVeil™ drug-coated balloon (DCB) is non … on the first drug-eluding stent (DES), the Johnson … System Chief, Division of Cardiovascular Diseases at Main Line … option for treating femoropopliteal arterial disease that minimizes patient …
-
Clopidogrel Outperforms Aspirin in Reducing Cardiovascular Events Post-PCI: SMART-CHOICE 3 Trial
19 Apr 2025 04:58 GMT
… strategy for patients undergoing percutaneous coronary intervention, identifying the most … of DAPT following PCI with drug-eluting stents.
For this purpose, the … risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE …
-
Fibrinogen/Albumin Ratio is Associated with the Occurrence of Contrast-Induced Acute Kidney Injury in Patients with Congestive Heart Failure
16 Apr 2025 23:49 GMT
… increased risk of cardiovascular diseases, including coronary artery disease and heart failure, and poorer … non-ST elevation acute coronary syndrome after implantation of drug-eluting stents. J of Renin …
-
APAC coronary stent market set to grow at 3.2% CAGR through 2034
16 Apr 2025 18:42 GMT
… sustained growth, driven by rising coronary artery disease (CAD) prevalence, an … on cardiovascular health, and significant price reductions for coronary stents through … managing CAD and acute coronary syndrome (ACS). Drug-eluting stents (DES) dominate both …
-
Refining DAPT strategies after drug coated balloon angioplasty
31 Mar 2025 10:58 GMT
Ovidio De Filippo, interventional cardiologist1,
Fabrizio D’Ascenzo, aassociate professor of cardiology1 2,
Gaetano Maria De Ferrari, professor of cardiology1 2
1Division of Cardiology, Cardiovascular and Thoracic Department, AOU Città della Salute e della …
-
The Association Between Preoperative Triglyceride Glucose Index and Postoperative Adverse Cardiovascular Events in Non-Cardiac Surgery: A Single-Center Study From China
12 Apr 2025 16:23 GMT
… -stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc … of coronary artery disease in different glucose metabolic states in patients with coronary heart …
-
APAC coronary stent market to grow 3.2% annually
11 Apr 2025 03:27 GMT
… by rising cases of coronary artery disease.
The coronary stent market in Asia-Pacific … , lower stent prices from centralised procurement, and increased focus on heart health … .
The report also said that drug eluting stents (DES) dominate the market due …
About
© 1995-2025